Anyhow, if you read the rest of my post, I agree - their interest expenses just nuts. The directors are getting their bonuses improving EBITDA but meanwhile NPAT suffers.
I wonder if this needs to be raised with management. I understand Barclay already holds a substantial interest in QMS, but STIs based only on EBITDA does not sound like an appropriate incentive that matches aligns director rem with shareholder interests.
QMS Price at posting:
70.5¢ Sentiment: None Disclosure: Held
